Preview

Bashkortostan Medical Journal

Advanced search

Prevention of Postoperative Scarring in Anti-Glaucoma Surgery

Abstract

The increase in ophthalmotonus after anti-glaucoma surgeries is associated with excessive scarring in the surgical intervention area. Many factors contribute to this: young age of the patient, associated chronic diseases, long-term use of antiglaucoma drops and others.

This review presents analysis of the literature on the prevention of scarring of the filter area after antiglaucoma surgeries. Possible post-operative complications and methods of their prevention are described, methods of preventing excessive scarring, including antimetabolites and steroids are presented. The authors conclude that numerous studies in this field indicate that surgeons are dissatisfied with existing methods of preventing excessive scarring, and search for better methods is relevant and promising.

About the Authors

F. A. Bakhritdinova
Ташкентская медицинская академия
Russian Federation


E. N. Bilalov
Ташкентская медицинская академия
Russian Federation


G. E. Kangilbaeva
Ташкентская медицинская академия
Russian Federation


B. E. Bilalov
Ташкентская медицинская академия
Russian Federation


References

1. Avetisov SE, Egorov EA, Moshetova LK, Neroev VV, Takhchidi KhP. Oftal'mologiya. Natsional'noe rukovodstvo. Kratkoe izdanie (Ophthalmology. National Guide. Brief edition). 2014:502-503. (In Russ)

2. Takhchidi K.P., Takhchidi E.K., Novikov S.V., Shatskikh A.V., Gorbunova K.S. Intraoperative prevention of scarring on the model of non-penetrating deep sclerectomy in vivo. Oftal'mokhirurgiya. 2012;4:56-60. (In Russ)

3. Babushkin A.E. Trabeculectomy: prevention of an excessive postoperative scarring (literature review). Tochka zreniya. Vostok – Zapad. 2017;4:128-132. (In Russ)

4. Bikbov M.M., Babushkin A.E., Orenburkina O.I. Current opportunities for the prevention of excessive scarring after glaucoma surgery using antimetabolites. Natsional'nyi zhurnal Glaukoma. 2019;18(3):55-60. (In Russ) https://doi.org/10.25700/NJG.2019.03.06

5. Egorov E.A., Kuroyedov A.V., Gorodnichiy V.V. [et al.] Early and long-term outcomes of glaucoma surgery the results of multicenter study in CIS countries. RMJ. Clinical ophthalmology. 2017;(1):25-34. (In Russ)

6. Erichev V.P., Khachatryan G.K. Glycosaminoglycan matrix in conjunctival-scleral scarring prevention after trabeculectomy. Natsional’nyi zhurnal glaukoma. 2018;17(1):37-42. (In Russ)

7. Fam JM, Wollstein G, Schuman JS. Chapter 27 - The role of ocular inflammation, fluid dynamics, and bleb morphology in surgical outcomes, Editor(s): Kevin Gillmann, Kaweh Mansouri, The Science of Glaucoma Management, Academic Press, 2023:287-303. (in Engl) https://doi.org/10.1016/B978-0-323-88442-6.00032-7.

8. Petrov SYu, Lovpache DzhN, Loskutov IA. [et al.] The influence of local IOP-lowering therapy on the anterior segment tissues and outcome of glaucoma filtering surgery. Ophthalmology Journal. 2017;10(4):41-47. doi: 10.17816/OV10441-47. (In Russ)

9. Fineide F, Lagali N, Adil MY. [et al.] Topical glaucoma medications - Clinical implications for the ocular surface. Ocul Surf. 2022;26:19-49. (in Engl) doi: 10.1016/j.jtos.2022.07.007.

10. Petrov S.Yu. Modern methods of controlling wound healing after fistulizing glaucoma surgery. Risk factors and antimetabolites. Oftal'mologiya. 2017; 14(1):5–11. (In Russ)

11. Popova E.V. Prophylaxis of operating zone scarring in the primary open-angle glaucoma surgery. Prakticheskaya meditsina. 2016;6(98):141-144. (In Russ)

12. Zhigalskaya T.A., Krivosheina O.I. Using cytostatics in refractory glaucoma surgery. Russian ophthalmological journal. 2018; 11 (3): 71-75 (In Russ). doi: 10.21516/2072-0076-2018-11-3-71-75

13. Fontana H., Nouri-Mahdavi K., Lumba J. [et al.] Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open angle glaucoma. Ophthalmology. 2006; 113(6):930-936. (in Engl)

14. Gutierrez-Ortiz C., Cabarga C., Teus M.A. Prospective evalution of preoperative factors associated with succeassful mitomycin C needling of failed filtracion blebs. Glaucoma. 2006; 15(2):98-102. (in Engl)

15. Zakhidov A.B., Khodzhaev N.S., Neresov Yu.E. Antiproliferativnyi effekt lokal'noi tsitokinoterapii v eksperimental'noi modeli antiglaukomatoznoi operatsii (Antiproliferative effect of local cytokine therapy in an experimental model of antiglaucoma surgery). Sb. nauch. statei VIII nauch.-prakt. konf. s mezhdunarodnym uchastiem «Fedorovskie chteniya». – М., 2009: 225-226. (In Russ)

16. Chudopal E.A., Dikinov Z.Kh., Chudopal S. M. Primenenie Tamerita kak ingibitora proliferativnykh protsessov posle antiglaukomatoznykh operatsii (Use of Tamerit as an inhibitor of proliferative processes after antiglaucoma operations). Mater. V Evro-Aziatskoi konf. po oftal'mokhirurgii. Ekaterinburg; 2009: 162-163. (in Russ)

17. Mimura T, Noma H, Inoue Y. [et al.] Early Postoperative Effect of Ripasudil Hydrochloride After Trabeculectomy on Secondary Glaucoma: A Randomized Controlled Trial, The Open Ophthalmology Journal. 2022; 16:22-27. (in Engl)

18. Kishimoto T, Ishida W, Nakajima I. [et al.] Promotion of conjunctival fibroblast-mediated collagen gel contraction by mast cells through up-regulation of matrix metalloproteinase release and activation. Exp Eye Res. 2022;218:108980. (in Engl) doi: 10.1016/j.exer.2022.108980.

19. Kim M, Lee C, Payne R. [et al.] Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review. Surv Ophthalmol. 2015;60(6):524-35. (in Engl) doi: 10.1016/j.survophthal.2015.04.003.

20. Mamikonyan V.R., Petrov S.Yu., Safonova D.M. VEGF inhibitors in glaucoma surgery. Ophthalmology Journal. 2016; 9(1):47–55. (In Russ)

21. Vandewalle E, Abegão PL, Van BT. [et al.] Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study. Br J Ophthalmol. 2014;98(1):73-8. (in Engl) doi: 10.1136/bjophthalmol-2013-303966.

22. Kiseleva O.A., Iomdina E.N., Kalinina O.M. [at al.] Method of prevention and treatment of excessive scarring after anti-glaucoma operation. Patent Rossiiskoi federatsii. 2012;(31). RU 2 465 872(13) C1. (In Russ)

23. Bikbov M.M., Babushkin A.E. Metody profilaktiki posleoperatsionnogo rubtsevaniya putei ottoka (Methods for the prevention of postoperative scarring of outflow routes). Glaukoma. Natsional'noe rukovodstvo. М.: GEOTAR-Media, 2013: 624-654. (In Russ)

24. Bikbov V., Babushkin A., Orenburkina O.I. Double trabeculectomy results in surgical treatment of glaucoma. Bulgarian Forum Glaucoma. 2015; 5 (1):15 – 18. (in Engl)

25. Bikbov М., Babushkin A., Chayka O. [at al.] Efficiency of drainage surgery for refractory glaucoma. Ophthalmology. Eastern Europe. 2015; 3 (26): 81-86. (In Russ)

26. Bikbov M.M., Babushkin A.E., Orenburkina O.I. [at al.] Efficiency of fistulizing surgery of secondary refractory glaucoma. Russian Ophthalmological Journal. 2016; 3: 5-11. (In Russ)

27. Petrov S.Yu., Antonov A.A., Makarova A.S. [et al.] The possibility of prolonging the hypotensive effect of trabeculectomy. Vestnik oftal'mologii. 2015; 131 (1): 75-81. (In Russ)

28. Thakur S, Ichhpujani P, Kumar S. Grafts in Glaucoma Surgery: A Review of the Literature. Asia Pac J Ophthalmol (Phila). 2017;6(5):469-476. (in Engl) doi: 10.22608/APO.2016123.

29. Sheha H, Tello C, Al-Aswad LA. [at al.] Outcomes of the Shunt Tube Exposure Prevention Study: A Randomized Clinical Trial. Ophthalmol Glaucoma. 2019;2(6):392-401. (in Engl) doi: 10.1016/j.ogla.2019.08.003.

30. Khairy H.F., Elsawey V.F. Trabeculectomy with mitomycin C versus trabeculectomy with amniotic membrane transplant: A mediumterm randomized, controlled trial. Glaucoma. 2015; 2(7):556-559. (in Engl)

31. Harizman N, Du J, Tania Tai TY. A Prospective Randomized Trial of Ahmed Glaucoma Drainage Device Implantation with or without Ologen Collagen Matrix. Ophthalmol Glaucoma. 2021;4(4):421-426. (in Engl) doi: 10.1016/j.ogla.2020.12.005.

32. Rascheskov A.Yu., Loskoutov I.A., Korneeva A.V., [at al.] Methods of Prevention of Excessive Scarring of the Filtration Cushion During Anti-Glaucoma Operations with Implantation of Ahmed Valve Type Drainage. Effective pharmacotherapy. 2023; 19 (27): 22–29. (in Russ) DOI 10.33978/2307-3586-2023-19-27-22-29.

33. Slonimskiy A.Yu., Alekseyev I.B., Dolgiy S.S. New possibilities of excessive postoperative scarring prophylaxis by glaucoma surgery. Oftal'mologiya. 2012;9(3):36-40. (In Russ)

34. Zakharova I.A., Makhmutov V.Y., Avdeev R.V. A Method for Preventing Scarring from Surgical Treatment of Glaucoma. Vestnik of experimental and clinical surgery IX. 2016;1:81-87. (in Russ) DOI: 10.18499/2070-478X-2016-9-1-81-87.


Review

For citations:


Bakhritdinova F.A., Bilalov E.N., Kangilbaeva G.E., Bilalov B.E. Prevention of Postoperative Scarring in Anti-Glaucoma Surgery. Bashkortostan Medical Journal. 2025;20(2):46-50. (In Russ.)

Views: 3


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1999-6209 (Print)